Skip to main content
Clinical Trials/IRCT2017021520258N33
IRCT2017021520258N33CompletedPhase 2

Compare the efficacy of nanocrystalline silver dressings compared with ?conventional dressings in patients with impaired upper limb crushed fingers

Vice chancellor for research, Arak University of Medical Sciences0 sites70 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 70 years (—)
Sex
All

Inclusion Criteria

  • age 18 to 70 years with Finger injury with damage to the muscle of the ?upper limb; crush injury in ?10 to20 centimeter in muscles.
  • Exclusion criteria: involvement of tendons, blood vessels, muscles, nerves and bones at the site of damage; systemic diseases such as cardiovascular disease, metabolic disorders, collagen vascular, immuno suppression (diabetes, transplant) malignant;   inflammatory and infectious diseases at the same time; malnutrition (important in wound healing); addiction; pregnancy; breastfeeding; need for limb amputation;Loss of consciousness and traumatic brain injury; need for further surgery on the wound; history of skin allergy to silver; infected wounds before applying the dressing first stage

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research, Arak University of Medical Sciences

Similar Trials